End-stage Liver Disease (ESLD)
7
4
6
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (7)
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
Restrictive Fluid Management In Liver Transplantation (REFIL)
Restrictive Fluid Management In Liver Transplantation (REFIL) - Pilot
View of Cerebral Perfusion in Liver Transplantation
RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial
A Physical Activity Program in End-state Liver Disease